Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: anin silicostructure-based approach

dc.contributor.author	Mutlu, Ozal
dc.contributor.author	Ugurel, Osman Mutluhan
dc.contributor.author	Sariyer, Emrah
dc.contributor.author	Ata, Oguz
dc.contributor.author	Inci, Tugba Gul
dc.contributor.author	Ugurel, Erennur
dc.contributor.author	Kocer, Sinem
dc.contributor.author	Turgut-Balik, Dilek
dc.date.accessioned	2021-12-21T08:47:34Z
dc.date.available	2021-12-21T08:47:34Z
dc.identifier.issn	0739-1102
dc.identifier.issn	1538-0254
dc.identifier.uri	https://doi.org/10.1080/07391102.2020.1819882
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2264
dc.description.abstract	In this study, the Nsp12-Nsp8 complex of SARS-CoV-2 was targeted with structure-based and computer-aided drug design approach because of its vital role in viral replication. Sequence analysis of RNA-dependent RNA polymerase (Nsp12) sequences from 30,366 d
dc.language.iso	English
dc.publisher	Taylor & Francıs Inc
dc.rights	Green Published, Bronze
dc.title	Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: anin silicostructure-based approach
dc.type	Article; Early Access
dc.relation.journal	Journal Of Bıomolecular Structure & Dynamıcs
dc.identifier.doi	10.1080/07391102.2020.1819882

Files in this item

Files	Size	Format	View
There are no files associated with this item.